Sierra Space to Support Cancer Research on First Dream Chaser® Mission to ISS Sierra Space, a leading commercial space company and defense technology provider, announced new initiatives to advance biopharmaceutical…
Waystar Expands Authorization Automation to Meet Healthcare Providers’ 2025 Priorities Waystar (Nasdaq: WAY), a leading provider of healthcare payment software, has introduced the Auth Accelerate solution, a significant enhancement to…
Sotera Health Reports Q4 and Full-Year 2024 Results; Offers 2025 Outlook Sotera Health Company (Nasdaq: SHC), a leading provider of sterilization solutions, lab testing, and advisory services for the healthcare…
Pear Suite Empowers Birthworkers with Innovative Technology for Maternal and Child Health Pear Suite, a digital health company dedicated to addressing social determinants of health (SDOH), is advancing its mission…
Smart Meter Reveals 5 SmartHealth Solutions to Boost Patient Engagement at HIMSS 2025 Smart Meter, a leader in remote patient monitoring (RPM) technology, is poised to revolutionize patient engagement with…
GE HealthCare Appoints New President and CEO for China GE HealthCare (Nasdaq: GEHC), a global leader in healthcare solutions, announced today that Yihao Zhang, the current president and CEO of…
Sermo Survey: 81% of Physicians Say Technical Proficiency is Equal to Clinical Expertise The 37th Barometer report from Sermo, a leading platform for healthcare professional (HCP) engagement offering real-time business…
Seqfirst-neo Study Highlights Impact of Genomic Testing in NICU, Exposing Gaps in Protocols GeneDx (Nasdaq: WGS), a leading provider of genomic insights aimed at improving health outcomes, announced today that…
Healx Doses First Patient in Phase 2 Trial of HLX-1502 for Neurofibromatosis Type 1 Healx, a clinical-stage biotech company utilizing AI to advance treatments for rare diseases, has announced that…
Samsung Bioepis Launches PYZCHIVA® (Biosimilar to Stelara) in the US Samsung Bioepis Co., Ltd. has announced the U.S. launch of PYZCHIVA® (ustekinumab-ttwe), a biosimilar to Stelara (ustekinumab). PYZCHIVA is approved…
Neuroendocrine Tumor Center of Excellence Re-Certified The Center for Neuroendocrine Tumors at the Bad Berka Central Clinic has been officially re-certified, continuing its distinction as a leading medical facility in…
Prisma Health Saves $450M with Systemwide Transformation Prisma Health, South Carolina’s largest healthcare provider, has long been at the forefront of delivering exceptional care across the state. However, the challenges…